Is ATRS A Good Stock To Buy Now?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first...
Posts Tagged ‘NASDAQ:ATRS’
Antares Pharma Inc (ATRS): Hedge Funds In Wait-and-See Mode
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Did Hedge Funds Make The Right Call On Antares Pharma Inc (ATRS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Hedge Funds Have Never Been This Bullish On Antares Pharma Inc (ATRS)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the...
Hedge Fund and Insider Trading News: Tom Steyer, Daniel Och, Netflix Inc (NFLX), Antares Pharma Inc (ATRS), and More
Iowa Caucus Success for Tom Steyer is to Exceed Expectations (The Gazette) CEDAR RAPIDS – California businessman Tom Steyer says he plans to spend...
Here is What Hedge Funds Think About Antares Pharma Inc (NASDAQ:ATRS)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, increasing oil prices and deteriorating...
Hedge Funds Are Selling Antares Pharma Inc (ATRS)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...
Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)
We at Insider Monkey have gone over 738 13F filings that hedge funds and famous value investors are required to file by the SEC. The 13F filings show...
Market Movers Today: SunPower Corporation (SPWR), Antares Pharma Inc (ATRS), NetApp Inc. (NTAP), Aaron’s, Inc. (AAN), and More
SunPower Corporation (NASDAQ:SPWR) (The Motley Fool) What happened: Shares of solar manufacturer SunPower Corp. (NASDAQ:SPWR) fell as much as 12.4% in...
Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what...
Five Penny Stocks To Buy Based on Smart Money Sentiment
No doubt, penny stocks are for investors with a greater than average risk appetite, but considering their inexpensiveness and the possibility of towering...
Next Big Biotech Stock To Buy: Hedge Funds’ New Moves
Both Antares Pharma Inc (NASDAQ:ATRS) and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) recently had their names attached to 13G forms, as two hedge...
Armistice Capital Massively Cuts Position In Spectrum Pharmaceuticals Inc. (SPPI), Pours It Into Antares Pharma Inc (ATRS)
In two separate filings with the U.S. Securities and Exchange Commission, Armistice Capital, led by Steven Boyd, disclosed massively cutting its activist...
Deerfield Management Trims Holding In Antares Pharma Inc (ATRS) Just Before Disastrous Setback
According to a recent filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has trimmed its stake in Antares...
Sanofi SA (ADR) (SNY), Biodel Inc (BIOD): Would It Be Foolish to Trust Unilife Corp (UNIS)?
Shares of drug delivery systems manufacturer Unilife Corp (NASDAQ:UNIS) recently rallied after it announced a long-term contract to sell prefilled syringes...
Merit Medical Systems, Inc. (MMSI): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
In the 21st century investor’s toolkit, there are a multitude of methods shareholders can use to track Mr. Market. Some of the most underrated are hedge...
Antares Pharma Inc (ATRS): A Critical Look
Recently, I enjoyed an article contributed by Adam Feuerstein (“AF article”) regarding Antares Pharma Inc (NASDAQ:ATRS) and its transformational...
Antares Pharma Inc (ATRS), ISIS Pharmaceuticals, Inc. (ISIS), Ligand Pharmaceuticals Inc. (LGND): 3 Pharma Stocks You Need to Watch for the Rest of 2013
It’s hard to believe, but 2013 is already more than halfway over. This year has been a good one for many pharmaceutical stocks — at least...
Antares Pharma Inc (ATRS): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Is Antares Pharma Inc (NASDAQ:ATRS) undervalued? The best stock pickers are getting more bullish. The number of long hedge fund positions advanced by...
Identifying the Biggest Gem in Antares Pharma Inc (ATRS)’s Pipeline
Following the publication of my article on the blockbuster potential of Antares Pharma Inc (NASDAQ:ATRS)‘s transformational product (Otrexup),...
Merit Medical Systems, Inc. (MMSI): Hedge Funds and Insiders Are Bearish, What Should You Do?
Merit Medical Systems, Inc. (NASDAQ:MMSI) was in 11 hedge funds’ portfolio at the end of the first quarter of 2013. MMSI has seen a decrease in...
Antares Pharma Inc (ATRS) Q1 Results Unimpressive, but Otrexup Could Be Catalyst
Antares Pharma Inc (NASDAQ:ATRS) announced its first-quarter results Wednesday morning but failed to impress the market. Shares were down around 3%...
Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)
Antares Pharma Inc (NASDAQ:ATRS) investors should pay attention to an increase in activity from the world’s largest hedge funds recently. In the...
Amarin Corporation plc (ADR) (AMRN), Antares Pharma Inc (ATRS): 3 FDA Decisions You Need to Watch in 2013
Sequester or no sequester, the folks at the Food and Drug Administration look to be quite busy in 2013. Their schedules are full with plenty of important...
Antares Pharma Inc (ATRS), ARMOUR Residential REIT, Inc. (ARR): 5 Fast Growers for Your Consideration
When building your portfolio, aim for diversification. You should aim to hold both large and small companies (plus mid-sized ones) and companies in a...
Antares Pharma Inc (ATRS) Earnings: An Early Look – Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report...
